The customer reported that during a stem cell collection procedure, the patient developed a fever and chills.He was transported to the emergency room and later was admitted to the icu and was given unknown medications.Approximately 15 hours after he was admitted to the icu, he developed septic shock symptoms.Per the customer, granulokine (filgrastim) was administered to the patient prior to the collection procedure.Patient information is not available at this time.The disposable kit is not available for return because it was discarded by the customer.
|
Investigation: a bacterial culture was taken from the patient and test results were negative.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Per the therapeutic apheresis handbook: a physician's reference, 2nd edition, first time procedure patients reactions may occur in approximately 4.8% of procedures, and 1.2% of procedure patients experience reactions to citrate, based on the results of a survey of therapeutic procedures.Of these reactions, most were mild and well tolerated.The cobe spectra system has many safety features.A donor and/or patient reaction can occur rapidly, however.It is imperative that the operator continuously monitor the cobe spectra system and the donor and/or patient.Root cause: this disposable set was unavailable for specific root cause analysis.Based on information provided by the customer, it is possible that patient exhibited a reaction to acd-a and/or eto.
|